Alzheimer disease - "It's okay, mama, if you want to go, it's okay"

被引:33
作者
Hurley, AC
Volicer, L
机构
[1] Northeastern Univ, Bouve Coll Hlth Sci, Brigham & Womens Hosp, Ctr Excellence Nursing Practice,Sch Nursing, Boston, MA 02115 USA
[2] Edith Nourse Rogers Mem Vet Med Ctr, Ctr Geriatr Res Educ & Clin, Bedford, MA USA
[3] Boston Univ, Sch Med, Boston, MA 02118 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 288卷 / 18期
关键词
D O I
10.1001/jama.288.18.2324
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
About 4 million people in the United States have Alzheimer disease (AD) and the number of incident cases is expected to more than double from 377000 in 1995 to 959000 in 2050. Patients, their families, and health care professionals struggle with a relentless and irreversible neurological syndrome that can last from 2 to 20 years. Alzheimer disease causes both cognitive and functional impairments that predispose the patient to behavioral symptoms, destroy intellectual capacity and personality, erase the ability to communicate one's wishes for care, and lead to life-threatening consequences. At the close of life, family members and clinicians face decisions regarding degrees of intensive medical care to be provided for treatment of the late-stage consequences of AD, including withdrawal of invasive interventions, initiation of hospice, and treatment of a range of progressive medical conditions. Physicians can assist patients with AD and their loved ones through the terminal phases of the illness by preparing them for the relentless progression of the disease and by supporting them through the intellectual and emotional conflicts accompanying the end of life.
引用
收藏
页码:2324 / 2331
页数:8
相关论文
共 91 条
[1]  
Ahronheim JC, 1996, CLIN GERIATR MED, V12, P379
[2]  
*ALZH ASS, 2002, STAT ALZH DIS
[3]  
[Anonymous], 1998, Hospice care for patients with advanced progressive dementia
[4]  
[Anonymous], SPR S ETH LAW AG
[5]   Pain threshold and tolerance in Alzheimer's disease [J].
Benedetti, F ;
Vighetti, S ;
Ricco, C ;
Lagna, E ;
Bergamasco, B ;
Pinessi, L ;
Rainero, I .
PAIN, 1999, 80 (1-2) :377-382
[6]  
Berger JT, 2000, J CLIN ETHIC, V11, P304
[7]  
BIRKS JS, 1997, DONEPEZIL MILD MODER
[8]  
BLASI ZV, 2002, J AM MED DIR ASSOC, V13, P57
[9]  
Brown J., 1988, CLIN MANAGEMENT ALZH, P29
[10]   How should clinicians discuss hospice for patients with dementia? Anticipating caregivers' preconceptions and meeting their information needs [J].
Casarett, D ;
Takesaka, J ;
Karlawish, J ;
Hirschman, KB ;
Clark, CM .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 (02) :116-122